pharmaceuticals

Gufic Biosciences Limited Q2 FY24 Earnings Conference Call Insights

● Nov 17, 2023

Key highlights from Gufic Biosciences Limited (GUFICBIO) Q2 FY24 Earnings Concall New Product Launches and Approvals Launched new products like...

Punjab Chemicals & Crop Protection Ltd Q2FY24; 13% fall in Revenue

● Nov 17, 2023

Started in 1975 as Punjab United Pesticides & Chemicals Limited (PUPCL) has now evolved as Punjab Chemicals and Crop Protection...

Morepen Laboratories Ltd Q2FY24; 31% rise in Profits

● Nov 17, 2023

Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical...

RPG Life Sciences Ltd Q2FY24; 30% rise in Profits

● Nov 15, 2023

RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients...

Glenmark Pharmaceuticals Limited Q2 FY24 Earnings Conference Call Insights

● Nov 15, 2023

Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q2 FY24 Earnings Concall Financial Results Revenue increased 6.3% YoY to INR35,879 million....

Wockhardt Ltd Q2FY24; 11% rise in Revenue

● Nov 14, 2023

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams...

Jubilant Ingrevia Ltd Q2FY24; 32% fall in Profits

● Nov 14, 2023

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers...

Marksans Pharma Limited Q2 FY24 Earnings Conference Call Insights

● Nov 13, 2023

Key highlights from Marksans Pharma Limited (MARKSANS) Q2 FY24 Earnings Concall Financial Performance Revenues grew 17% year-on-year to INR531 crores...

Procter & Gamble Health Ltd Q2FY24; 3% rise in Profits

● Nov 13, 2023

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing...

Aurobindo Pharma Limited Q2 FY24 Earnings Conference Call Insights

● Nov 10, 2023

Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q2 FY24 Earnings Concall Revenue Growth Revenue grew 25.8% year-on-year to INR7,219 crores,...